DE60323482D1 - Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken - Google Patents

Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken

Info

Publication number
DE60323482D1
DE60323482D1 DE60323482T DE60323482T DE60323482D1 DE 60323482 D1 DE60323482 D1 DE 60323482D1 DE 60323482 T DE60323482 T DE 60323482T DE 60323482 T DE60323482 T DE 60323482T DE 60323482 D1 DE60323482 D1 DE 60323482D1
Authority
DE
Germany
Prior art keywords
shell
release
dosage form
core
api
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323482T
Other languages
German (de)
English (en)
Inventor
Chen-Chao Wang
Jaedeok Yoo
Esteban Bornancini
Willie J Roach
Monica Rewachand Motwani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of DE60323482D1 publication Critical patent/DE60323482D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00—Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10—Processes of additive manufacturing
    • B29C64/141—Processes of additive manufacturing using only solid materials
    • B29C64/153—Processes of additive manufacturing using only solid materials using layers of powder being selectively joined, e.g. by selective laser sintering or melting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00—Materials specially adapted for additive manufacturing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60323482T 2002-05-06 2003-05-06 Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken Expired - Lifetime DE60323482D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37844902P 2002-05-06 2002-05-06
US42509402P 2002-11-08 2002-11-08
PCT/US2003/014376 WO2003092633A2 (en) 2002-05-06 2003-05-06 Diffusion-controlled dosage form and method of fabrication including three dimensional printing

Publications (1)

Publication Number Publication Date
DE60323482D1 true DE60323482D1 (de) 2008-10-23

Family

ID=29406838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323482T Expired - Lifetime DE60323482D1 (de) 2002-05-06 2003-05-06 Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken

Country Status (9)

Country Link
US (2) US8088415B2 (enExample)
EP (1) EP1503741B1 (enExample)
JP (1) JP5041663B2 (enExample)
AT (1) ATE407665T1 (enExample)
AU (1) AU2003232078A1 (enExample)
CA (1) CA2483028C (enExample)
DE (1) DE60323482D1 (enExample)
ES (1) ES2316791T3 (enExample)
WO (1) WO2003092633A2 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60323482D1 (de) 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
EP2184058B1 (en) * 2003-09-26 2012-02-08 ALZA Corporation Drug coating providing high drug loading and methods for providing the same
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
JPWO2006004069A1 (ja) * 2004-07-01 2008-04-24 日本碍子株式会社 微小カプセルおよびその製造方法
WO2008110337A2 (en) * 2007-03-09 2008-09-18 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
EP2227226B1 (en) * 2007-12-21 2016-10-26 Johnson & Johnson Consumer Inc. Manufacture of a tablet
CN101716162B (zh) * 2009-11-26 2012-11-14 扬州中宝制药有限公司 一种氨茶碱缓释胶囊及其制备方法
US8251837B2 (en) * 2010-08-11 2012-08-28 Nike, Inc. Floating golf ball
EP2651399A2 (en) 2010-12-13 2013-10-23 Purdue Pharma LP Controlled release dosage forms
US9381154B2 (en) * 2011-06-09 2016-07-05 Xerox Corporation Direct inkjet fabrication of drug delivery devices
US8888480B2 (en) 2012-09-05 2014-11-18 Aprecia Pharmaceuticals Company Three-dimensional printing system and equipment assembly
KR101697105B1 (ko) 2012-09-05 2017-01-17 아프레시아 파마슈티칼스 컴퍼니 3차원 인쇄 시스템 및 장비 어셈블리
US20140099351A1 (en) * 2012-10-04 2014-04-10 Axxia Pharmaceuticals, Llc Process for making controlled release medical implant products
HK1216513A1 (zh) 2013-03-15 2016-11-18 阿普雷奇亚制药有限责任公司 包含左乙拉西坦的快速分散劑型
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
JP6233996B2 (ja) 2013-08-16 2017-11-22 ザ エクスワン カンパニー ３次元印刷される金属鋳造用鋳型及び同鋳型の製造方法
US20160243621A1 (en) 2013-10-17 2016-08-25 The Exone Company Three-Dimensional Printed Hot Isostatic Pressing Containers and Processes for Making Same
EP2875933B1 (de) * 2013-11-25 2019-04-03 MTU Aero Engines GmbH Dokumentation generativer Herstellungsverfahren
MX2016007786A (es) 2013-12-16 2017-03-03 Massachusetts Inst Technology Formulaciones de sal de micronutrientes fortificadas.
EP3763383A1 (en) 2013-12-16 2021-01-13 Massachusetts Institute Of Technology Micromolded or 3-d printed pulsatile release vaccine formulations
ES2745763T3 (es) 2013-12-23 2020-03-03 The Exone Co Métodos y sistemas para la impresión en tres dimensiones utilizando múltiples fluidos aglutinantes
US11001048B2 (en) 2013-12-23 2021-05-11 The Exone Company Method of three-dimensional printing using a multi-component build powder
IL232696B (en) 2014-05-19 2018-08-30 Technion Res & Dev Foundation Compound and method for detecting molecules of interest
US20170120329A1 (en) 2014-05-29 2017-05-04 The Exone Company Process for Making Nickel-Based Superalloy Articles by Three-Dimensional Printing
WO2016011098A2 (en) 2014-07-17 2016-01-21 The Exone Company Methods and apparatuses for curing three-dimensional printed articles
EP3191084B2 (en) * 2014-09-08 2022-08-31 University of Central Lancashire Solid dosage form production
US9844930B2 (en) 2014-11-05 2017-12-19 Xerox Corporation 3D printing of digestible shells for medicaments
EP3227109B1 (en) 2014-12-03 2020-08-19 The Exone Company Process for making densified carbon articles by three dimensional printing
CN106236715B (zh) * 2015-06-03 2021-05-07 南京三迭纪医药科技有限公司 药品剂型及其使用
EP3302442B1 (en) 2015-06-03 2024-10-16 Triastek, Inc. Dosage forms and use thereof
WO2017010938A1 (en) * 2015-07-16 2017-01-19 National University Of Singapore Printing drug tablets with fully customizable release profiles for personalized medicine
CN116423825A (zh) 2015-08-21 2023-07-14 阿普雷奇亚制药有限责任公司 三维打印系统和设备组件
GB201519128D0 (en) * 2015-10-29 2015-12-16 Univ Central Lancashire Solid forms and methods of preparing the same
EP3981392A1 (en) 2016-05-05 2022-04-13 Triastek, Inc. Controlled release dosage form
US12303603B2 (en) * 2016-06-20 2025-05-20 Sciperio, Inc Real-time compounding 3D printer
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
GB201612853D0 (en) 2016-07-25 2016-09-07 Univ Central Lancashire Solid dosage form production
EP3321002A1 (en) * 2016-11-15 2018-05-16 Höganäs AB Feedstock for an additive manufacturing method, additive manufacturing method using the same, and article obtained therefrom
DE102017200773A1 (de) 2017-01-18 2018-07-19 Eos Gmbh Electro Optical Systems Verfahren zum Nachbehandeln und Nachbehandlungssytem
US12102721B2 (en) * 2017-01-26 2024-10-01 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
US10369557B2 (en) 2017-04-12 2019-08-06 International Business Machines Corporation Three-dimensional printed objects for chemical reaction control
US20210213678A1 (en) * 2017-04-28 2021-07-15 Hewlett-Packard Development Company, L.P. Producing diffusion-controlled release devices
WO2019025869A1 (en) * 2017-07-31 2019-02-07 Teva Pharmaceutical Industries Limited GALENIC FORMS WITH CONTROLLED RELEASE MANUFACTURED IN ADDITIVE MANNER
US11642841B2 (en) 2017-10-13 2023-05-09 Ut-Battelle, Llc Indirect additive manufacturing process
US10350822B1 (en) 2018-01-09 2019-07-16 Triastek Inc. Dosage forms with desired release profiles and methods of designing and making thereof
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate
DE102018107585B3 (de) * 2018-03-29 2019-03-28 Universität Rostock Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
WO2019199328A1 (en) * 2018-04-13 2019-10-17 Hewlett-Packard Development Company, L.P. Three-dimensional printing
CN108939162B (zh) * 2018-07-10 2021-11-19 上海理工大学 一种介孔生物玻璃/海藻酸钠-海藻酸钠分层骨组织工程支架的制备方法
GB201813186D0 (en) 2018-08-13 2018-09-26 Univ Central Lancashire Solid dosage from production
AU2019337800A1 (en) * 2018-09-14 2021-05-13 Merck Patent Gmbh Process for the preparation of a coated solid pharmaceutical dosage form
US11278501B2 (en) 2018-10-15 2022-03-22 Aprecia Pharmaceuticals LLC Method and system for forming a dosage form within a packaging
US11254617B2 (en) 2019-01-09 2022-02-22 Ut-Battelle, Llc Indirect additive manufacturing process using amine-containing adhesive polymers
US12103229B2 (en) * 2019-03-15 2024-10-01 Ricoh Company, Ltd. Jettable temporary binders to create removable support materials
US11724486B2 (en) 2019-07-09 2023-08-15 Kyndryl, Inc. Printing customized medication based on current user data and medical records of the user
AU2020329531A1 (en) * 2019-08-14 2022-03-31 Merck Patent Gmbh Method for additive manufacture of a product, manufacturing device and solid pharmaceutical dosage form
GB201913972D0 (en) 2019-09-27 2019-11-13 Univ Ulster Pharmaceutical Delivery Device and method of manufacture
ES2828509B2 (es) 2019-11-26 2022-03-09 Fund Idonial Composicion para la impresion 3d de farmacos semisolidos
EP3871859A1 (en) * 2020-02-26 2021-09-01 Hewlett-Packard Development Company, L.P. Three-dimensional printing
JP7624750B2 (ja) * 2020-03-02 2025-01-31 クラフト ヘルス プライベート リミテッド 持続的薬物放出のための経口剤形
CN115835856A (zh) 2020-05-13 2023-03-21 麻省理工学院 聚合物微装置的组合物以及其在癌症免疫疗法中的用途
MX2022016117A (es) 2020-06-26 2023-04-05 Aprecia Pharmaceuticals LLC Tabletas rapidamente orodispersables que tienen una cavidad interior.
US20230390193A1 (en) 2020-10-30 2023-12-07 Triastek, Inc. Gastroretentive pharmaceutical dosage form
US12251208B2 (en) 2020-11-30 2025-03-18 International Business Machines Corporation Time controlled medication
KR102723494B1 (ko) * 2020-12-24 2024-10-31 동아제약 주식회사 적층 방식으로 제조된 방출 조절용 약제학적 조성물
CN112940690B (zh) * 2021-02-05 2021-11-02 中国科学院苏州纳米技术与纳米仿生研究所南昌研究院 一种具有豆荚结构的相变储能材料及其制备方法与应用
WO2024108084A1 (en) * 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Functionally-dividable orodispersive dosage form

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US948297A (en) * 1909-07-24 1910-02-01 John A Stone Corn-husker.
US986148A (en) * 1910-05-09 1911-03-07 Hoechst Ag Derivative of oxyarylarsinic acids and process of making same.
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5204055A (en) * 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
NZ286242A (en) * 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
US5775402A (en) * 1995-10-31 1998-07-07 Massachusetts Institute Of Technology Enhancement of thermal properties of tooling made by solid free form fabrication techniques
US5490882A (en) * 1992-11-30 1996-02-13 Massachusetts Institute Of Technology Process for removing loose powder particles from interior passages of a body
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US6280771B1 (en) * 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
US6238704B1 (en) * 1996-09-13 2001-05-29 Shionogi & Co., Ltd. Sustained-release preparation utilizing thermal change and process for the production thereof
JP4563516B2 (ja) * 1997-02-20 2010-10-13 マサチューセッツ インスティテュート オブ テクノロジー 迅速分散性を示す投与剤形、その使用法並びにその製造方法
US6213168B1 (en) * 1997-03-31 2001-04-10 Therics, Inc. Apparatus and method for dispensing of powders
WO1998043762A2 (en) * 1997-03-31 1998-10-08 Therics, Inc. Method for dispensing of powders
US6547994B1 (en) * 1998-11-13 2003-04-15 Therics, Inc. Rapid prototyping and manufacturing process
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
ES2257412T3 (es) * 2000-05-18 2006-08-01 Therics, Inc. Encapsulacion de un nucleo toxico en una region no toxica en una forma de dosificacion oral.
US20020084290A1 (en) * 2000-11-10 2002-07-04 Therics, Inc. Method and apparatus for dispensing small volume of liquid, such as with a weting-resistant nozzle
DE60323482D1 (de) 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
US20050015728A1 (en) * 2003-07-17 2005-01-20 International Business Machines Corporation Method, system, and program product for customizing a user interface

Also Published As

Publication number Publication date
EP1503741A2 (en) 2005-02-09
ATE407665T1 (de) 2008-09-15
JP2005524702A (ja) 2005-08-18
WO2003092633A3 (en) 2004-04-08
EP1503741B1 (en) 2008-09-10
CA2483028C (en) 2011-04-05
WO2003092633A2 (en) 2003-11-13
JP5041663B2 (ja) 2012-10-03
US20040005360A1 (en) 2004-01-08
ES2316791T3 (es) 2009-04-16
US8088415B2 (en) 2012-01-03
AU2003232078A1 (en) 2003-11-17
CA2483028A1 (en) 2003-11-13
US20120177696A1 (en) 2012-07-12
US8465777B2 (en) 2013-06-18

Similar Documents

Publication Publication Date Title
DE60323482D1 (de) Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
WO2009007372A3 (en) A bone tissue implant comprising strontium ions
UA101309C2 (ru) Антагонисты активина-actrii и их применение для повышения уровня эритроцитов
MXPA02009547A (es) Composicion de vitamina de liberacion sostenida.
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
BRPI0912411B8 (pt) uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune
WO2003084539A3 (en) New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
MX348282B (es) Formulaciones farmaceuticas de liberacion controlada de nitazoxanida.
WO2007078427A3 (en) Diffusion-hardened medical implant
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
DE502004005154D1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein-wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
WO2005115530A3 (en) Seizure therapy method and apparatus
WO2008045228A3 (en) Medical devices having porous regions for controlled therapeutic agent exposure or delivery
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
MX337937B (es) Preparacion de liberacion controlada.
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
AU2003238023A1 (en) Method of evaluating myelosuppressive state
TNSN08284A1 (en) Masking the taste of powders
SE0103211D0 (sv) New formulations and use thereof
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
TW200635617A (en) Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form
BRPI1009003A2 (pt) "método para expressão recombinante de um ccn1 humano, uso de um ccn1 humano, anticorpo contra ccn1 humano, uso de um anticorpo contra ccn1 humano, método para a fabricação de um medicamento para o tratamento de doenças e composição farmacêutica"
MY139719A (en) Oral dosage form for controlled drug release
IL250852B (en) Periodontal preparation
Kohal et al. Influence of loading and aging on the fracture strength of an injection‐molded two‐piece zirconia implant restored with a zirconia abutment

Legal Events

Date Code Title Description
8364 No opposition during term of opposition